Zydus Lifesciences Rises 2% on Sterling Biotech Deal Update
Zydus Lifesciences jumps to Rs 1,125 on 29 June, up 2%, after extending its Sterling Biotech API acquisition deadline to 30 September 2026. Active Pharmaceutical...
Tag : USFDA
Jubilant Pharmova Arm Gets USFDA Nod for Antacid Drug
Shares of Jubilant Pharmova Limited touched Rs 985.95 on 25 June after its arm won a tentative USFDA nod for an antacid drug. Most people...
Lupin Shares End 3% Higher on USFDA Nod for Schizophrenia, Bipolar Disorder Drug
Shares of Lupin Ltd ended 3% higher after hitting a day’s high of Rs 1,953.80 on 3rd September, following the company’s announcement that it has...
Zydus Lifesciences Gets Four USFDA Observations at Baddi Plant, Ahmedabad Unit Clears Inspection; Shares Flat
Shares of Zydus Lifesciences Ltd are trading flat after touching a day’s high of Rs 1,002.85 on 14th August. This came after the company said...
Marksans Pharma Gets USFDA Nod for Acid Reflux Drug, Shares Trade Flat
Shares of Marksans Pharma Ltd were trading flat on 8th August after touching a day’s high of Rs 217.49, despite the company securing final approval...
Biocon Hits 52-Week High After USFDA Nod for Key Diabetes Drug, Shares Up 1%
Shares of Biocon Ltd rose 1% to touch a day’s high of Rs 405.90 on 16th July, after the United States Food & Drug Administration...
Shilpa Medicare Jumps 5% After Bengaluru Unit Clears US FDA Inspection
Shares of Shilpa Medicare Ltd rose 5% to touch a day’s high of Rs 937.10 on 16th July, after the company announced it had received...
Glenmark Pharma Gets USFDA Warning for Indore Unit; Shares Trading Flat
Shares of Glenmark Pharma Ltd are trading flat after touching a day’s high of Rs 2,197.70 on 14th July, following the company’s disclosure that it...
Zydus Oncology Plant Gets 2 FDA Observations; Shares Trading Flat
Shares of Zydus Lifesciences Ltd are trading flat after hitting a day’s high of Rs 958 on 19th June. This comes after the company announced...
Biocon Shares Slump 4% as Bengaluru API Unit Gets VAI Tag
Shares of Biocon Ltd slumped 4% on Monday, 9 December, after the company’s Bengaluru Unit received an Establishment Inspection Report (EIR) with a Voluntary Action...